Clinical trial of three Homoeopathic drugs on patients

To clinically verify three drugs (Adansonia, Cimetidine and Cineraria) already proved by CCRH in different potencies in the clinical set up of Dr B R Sur Homoeopathic Medical College Hospital and Research Centre (SHMC) OPD and IPD - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077680

Enrollment

150

Registered

2024-12-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A09- Infectious gastroenteritis and colitis, unspecified Health Condition 2: M95-M95- Other disorders of the musculoskeletal system and connective tissue Health Condition 3: G40-G47- Episodic and paroxysmal disorders Health Condition 4: E00-E89- Endocrine, nutritional and metabolic diseases Health Condition 5: L00-L99- Diseases of the skin and subcutaneous tissue Health Condition 6: K00-K95- Diseases of the digestive system Health Condition 7: H00-H59- Diseases of the eye and

Interventions

Intervention1: Adansonia, Cimetidine, Cineraria: All the 3 drugs will be administered in different potencies- 6C, 12C, 30 and 200 potencies, selected on the basis of homoeopathic principles. The dose

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patients of all age group (18-80 years) and both sexes. 2-Patients exhibiting symptoms of any system which are not highly pathological. 3-Patients willing to take the medicines/ participate in research in the clinical verification. 4-Acute and chronic cases will be taken up for the study

Exclusion criteria

Exclusion criteria: 1-Patients suffering from any terminal illnesses. 2-Patients on immuno-suppressant drugs. 3-Patients of deep and advanced pathologies.

Design outcomes

Primary

Measure	Time frame
To validate the symptoms observed in the patients matching with the symptoms of the prover established during drug proving for particular medicine, and finding the extent of improvement in patients symptoms on the basis of law of similiaTimepoint: One year (12 Months)	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Neeraj Gupta

Dr. B R Sur Homoeopathic Medical College, Hospital and Research Centre

principal_shmc@yahoo.com09212013664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026